This article was originally published in The Gray Sheet
Executive SummaryOffering $150 mil. of 5.5% Euronotes maturing July 8, 1998. The notes are being offered in $1,000, $10,000 and $100,000 denominations at an issue price of 1.01369 times the value of the note. Interest will be paid annually. Payment for the notes is due July 8. The firm says the offering is part of a strategy to transfer short term floating rate debt into fixed rate medium and long term debt. Morgan Stanley International is lead manager for the offering.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.